Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

Magnitude and durability of SARS-CoV-2 S-binding antibody titers in the pre-variant era among healthcare workers in NYC

4 Apr 2022
Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

4 Apr 2022
The emergence and limited spread of the Mu SARS-CoV-2 variant

The emergence and limited spread of the Mu SARS-CoV-2 variant

4 Apr 2022
SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

4 Apr 2022
Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

4 Apr 2022
Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

Acute respiratory distress syndrome may increase death risk among young COVID-19 patients

4 Apr 2022
The effects of SARS-CoV-2 infection in different ancestry origins from the same region

The effects of SARS-CoV-2 infection in different ancestry origins from the same region

4 Apr 2022
Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

4 Apr 2022
Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

Study shows SARS-CoV-2 antibodies persist for one-year post-infection with protection from other variants

4 Apr 2022
Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

4 Apr 2022
Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

Evidence SARS-CoV-2 undergoes ADAR-mediated A-to-I RNA editing in human cells

4 Apr 2022
COVID-19 study proves ivermectin ineffective

COVID-19 study proves ivermectin ineffective

4 Apr 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

4 Apr 2022
How well does the BNT162b2 vaccine protect children and teens against Omicron?

How well does the BNT162b2 vaccine protect children and teens against Omicron?

4 Apr 2022
Smart toilets for passive surveillance of SARS-CoV-2

Smart toilets for passive surveillance of SARS-CoV-2

3 Apr 2022
The effect of COVID-19 on the lung function of young adults

The effect of COVID-19 on the lung function of young adults

3 Apr 2022
Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

3 Apr 2022
TLR7 and MARK1 genomic variants impact COVID-19 prognosis

TLR7 and MARK1 genomic variants impact COVID-19 prognosis

3 Apr 2022
An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

3 Apr 2022
Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

3 Apr 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback